Arcutis Biotherapeutics Inc (ARQT) (Q3 2026) Earnings Call Highlights: Revenue Surges 45% to ...
Arcutis Biotherapeutics Inc (ARQT) posted strong Q3 2026 net product revenue growth, lifted full-year guidance to $535-$545 million, and outlined multiple pipeline catalysts despite elevated expenses. Related Stocks: ARQT ,